CITIGROUP INC - BRAINSTORM CELL THERAPEUTICS ownership

BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 25 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of BRAINSTORM CELL THERAPEUTICS
ValueSharesWeighting
Q2 2021$10,000
-44.4%
2,750
-42.3%
0.00%
Q1 2021$18,000
-56.1%
4,768
-48.0%
0.00%
Q4 2020$41,000
-41.4%
9,163
+122.3%
0.00%
Q3 2020$70,000
-1.4%
4,122
-35.2%
0.00%
Q2 2020$71,000
+238.1%
6,362
+39.2%
0.00%
Q1 2020$21,000
+75.0%
4,572
+66.3%
0.00%
Q4 2019$12,0000.0%2,750
-6.8%
0.00%
Q3 2019$12,000
+1100.0%
2,950
+1375.0%
0.00%
Q2 2019$1,0000.0%2000.0%0.00%
Q1 2019$1,0000.0%2000.0%0.00%
Q4 2018$1,0000.0%2000.0%0.00%
Q3 2018$1,0000.0%200
-45.9%
0.00%
Q2 2018$1,0000.0%3700.0%0.00%
Q1 2018$1,0000.0%3700.0%0.00%
Q4 2017$1,000
-50.0%
3700.0%0.00%
Q3 2017$2,0000.0%3700.0%0.00%
Q2 2017$2,0000.0%3700.0%0.00%
Q1 2017$2,000
+100.0%
3700.0%0.00%
Q4 2016$1,0000.0%3700.0%0.00%
Q3 2016$1,0000.0%3700.0%0.00%
Q2 2016$1,0000.0%370
-2.6%
0.00%
Q1 2016$1,0000.0%380
-28.3%
0.00%
Q4 2015$1,000530
+1506.1%
0.00%
Q2 2015$0
-100.0%
33
-96.6%
0.00%
Q1 2015$4,0009580.00%
Other shareholders
BRAINSTORM CELL THERAPEUTICS shareholders Q3 2016
NameSharesValueWeighting ↓
ABNER HERRMAN & BROCK LLC 241,500$1,093,0000.17%
OCCUDO QUANTITATIVE STRATEGIES LP 90,584$410,0000.13%
EPIQ PARTNERS, LLC 10,550$48,0000.03%
Phoenix Holdings Ltd. 173,683$799,0000.02%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 5,500$25,0000.02%
CFO4Life Group, LLC 12,003$54,0000.02%
HighPoint Advisor Group LLC 15,733$115,0000.01%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 357,761$1,619,0000.01%
Virtu Financial LLC 24,484$111,0000.01%
ETF MANAGERS GROUP, LLC 93,902$435,0000.01%
View complete list of BRAINSTORM CELL THERAPEUTICS shareholders